Yousif Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Other funds holding SUPN
HWAM
WCM
CNAM
ETC
YIH
SOADOR
LSERS
FSA
Yousif Capital Management's SUPN Position: Q2 2026 in Review
Yousif Capital Management increased its Supernus Pharmaceuticals (SUPN) stake by 0.67% in Q2 2026, buying an estimated $5K and bringing the position to 15,656 shares worth $728K. The position accounts for 0.01% of the portfolio, ranked #1212.
Yousif Capital Management first reported a position in SUPN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.62M in Q1 2022. 44 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- Yousif Capital Management held 15,656 shares of Supernus Pharmaceuticals worth $728K as of Q2 2026.
- Yousif Capital Management bought 104 Supernus Pharmaceuticals shares in Q2 2026, an estimated $5K.
- Supernus Pharmaceuticals made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1212 holding.
- Yousif Capital Management first reported a position in Supernus Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- Yousif Capital Management's Supernus Pharmaceuticals position peaked at $1.62M in Q1 2022.
- 44 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.